Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
January 29, 2019
Nicox Announces U.S. FDA Acceptance of Investigational New Drug Application for NCX 4251 Phase 2 Trial in Blepharitis
Sophia Antipolis, France -- Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the U.S. Food and Drug Administration (FDA) has completed ...
January 29, 2019
4D Pharma Announces Publication of Data Highlighting Immuno-Stimulatory Properties of MRx0518
LEEDS, England, January 29, 2019 /PRNewswire/ -- 4D pharma plc (DDDD.L), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the publication of a ...
January 29, 2019
OncoCyte Announces Successful Results of DetermaVu™ R&D Validation Study
ALAMEDA, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, ...
January 29, 2019
Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK
VANCOUVER , Jan 29, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
January 29, 2019
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder
JERUSALEM, Jan. 29, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRIN.TA), a global leader in the advanced non-invasive treatment of brain disorders, today announced that its ...
January 29, 2019
Allakos Announces Positive Phase 2 Results in Patients with Cholinergic Urticaria and Symptomatic Dermographism
REDWOOD CITY, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell ...
January 29, 2019
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced results of its recently completed HepTcell Phase 1 ...
January 29, 2019
ProQR Announces “ProQR Vision 2023” Strategy at its Annual R&D Day
LEIDEN, the Netherlands & CAMBRIDGE, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation ...
January 29, 2019
Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
Daix (France), January 29th, 2019 - Inventiva S.A. ("Inventiva"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis ("NASH"), systemic sclerosis and mucopolysaccharidosis ("MPS"), today ...
January 29, 2019
PolarityTE Names Board Member David Seaburg as President of Corporate Development
SALT LAKE CITY, Jan. 29, 2019 /PRNewswire/ -- PolarityTE, Inc.(PTE) announced today that David Seaburg will join the Company in the newly-created role of President ...
January 29, 2019
Inspire Medical Systems, Inc. Announces FDA Approval of New Sensing Lead
MINNEAPOLIS, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
January 28, 2019
Nicox Establishes High-Profile Glaucoma Clinical Advisory Board
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the formation of Nicox Glaucoma Clinical Advisory Board, composed of key clinical investigators ...
January 28, 2019
Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
SAN DIEGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced publications expanding on previously reported results from three of the company’s ...
January 28, 2019
electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference
BASKING RIDGE, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (ECOR), a commercial-stage bioelectronic medicine company, today announced Chief Executive Officer, Frank Amato and ...
January 28, 2019
Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
WARREN, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that data from the ...
January 28, 2019
Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
DUBLIN, Jan. 28, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first patient in a registrational Phase ...
January 24, 2019
Changes to Zealand Pharma’s Executive Management
Copenhagen, Denmark, January 23, 2019 – Zealand Pharma A/S today announced changes to its Executive Management. Following the resignation of Britt Meelby Jensen on 26 ...
January 24, 2019
HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program
TUCSON, Ariz., Jan. 23, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, ...
January 24, 2019
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
NEW YORK--(BUSINESS WIRE)--UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on ...
January 24, 2019
Basilea announces collaboration to study derazantinib and atezolizumab (Tecentriq®) in urothelial cancer
Basel, Switzerland, January 24, 2019 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that it entered into a collaboration with Roche (SIX: RO, ROG) to explore ...
Page 18 of 138